{
	"symbol": "HBP",
	"name": "Helix BioPharma Corp.",
	"price": 0.97,
	"priceChange": 0,
	"percentChange": 0,
	"exchangeName": "Toronto Stock Exchange",
	"exShortName": "TSX",
	"exchangeCode": "TSX",
	"marketPlace": null,
	"sector": "Healthcare",
	"industry": "Biotechnology",
	"volume": 3000,
	"openPrice": 0.97,
	"dayHigh": 0.97,
	"dayLow": 0.97,
	"MarketCap": 71931093,
	"MarketCapAllClasses": 71931093,
	"peRatio": "",
	"prevClose": 0.97,
	"dividendFrequency": null,
	"dividendYield": null,
	"dividendAmount": null,
	"dividendCurrency": null,
	"beta": -0.805423,
	"eps": null,
	"exDividendDate": "",
	"longDescription": "Helix BioPharma Corp is a clinical-stage biopharmaceutical company. It is focused on cancer drug development. The company develops therapies in the field of immuno-oncology based on its proprietary technology mainly in the areas of cancer prevention and treatment. Its pipeline candidates are Tumor Defence Breaker L-DOS47, and, V-DOS47 among others.",
	"fulldescription": "Helix BioPharma Corp is a clinical-stage biopharmaceutical company. It is focused on cancer drug development. The company develops therapies in the field of immuno-oncology based on its proprietary technology mainly in the areas of cancer prevention and treatment. Its pipeline candidates are Tumor Defence Breaker L-DOS47, and, V-DOS47 among others.",
	"website": "https://www.helixbiopharma.com",
	"email": "helix@helixbiopharma.com",
	"phoneNumber": "+1 905 841-2300",
	"fullAddress": "9120 Leslie Street,Suite 205, Richmond Hill, ON, CA",
	"employees": "7",
	"shareOutStanding": 74155765,
	"totalDebtToEquity": "",
	"totalSharesOutStanding": 74155765,
	"sharesESCROW": null,
	"vwap": 0.97,
	"dividendPayDate": null,
	"weeks52high": 1.35,
	"weeks52low": 0.5,
	"alpha": 0.001075,
	"averageVolume10D": 3382,
	"averageVolume20D": 2286,
	"averageVolume30D": 1649,
	"averageVolume50D": 2692,
	"priceToBook": -3785.85,
	"priceToCashFlow": -19.1,
	"returnOnEquity": "",
	"returnOnAssets": -759.61,
	"day21MovingAvg": 0.930476,
	"day50MovingAvg": 0.927,
	"day200MovingAvg": 0.9209,
	"dividend3Years": "",
	"dividend5Years": "",
	"datatype": "equity",
	"issueType": "CS",
	"close": 0.97,
	"qmdescription": "Biotechnology",
	"__typename": "Company"
}